These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 32510624

  • 1. Young-onset diabetes, nutritional therapy and novel insulin delivery systems: a report from the 21st Hong Kong Diabetes and Cardiovascular Risk Factors - East Meets West Symposium.
    Luk AOY, Kong APS, Basu A.
    Diabet Med; 2020 Aug; 37(8):1234-1243. PubMed ID: 32510624
    [Abstract] [Full Text] [Related]

  • 2. Current management of diabetes mellitus and future directions in care.
    Chatterjee S, Davies MJ.
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [Abstract] [Full Text] [Related]

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S, Peter Chase H.
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [Abstract] [Full Text] [Related]

  • 4. New and Emerging Technologies in Type 1 Diabetes.
    Sherwood JS, Russell SJ, Putman MS.
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):667-678. PubMed ID: 33153673
    [Abstract] [Full Text] [Related]

  • 5. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ, Hillard MA, Balliro C, Magyar KL, Selagamsetty R, Sinha M, Grennan K, Mondesir D, Ekhlaspour L, Zheng H, Damiano ER, El-Khatib FH.
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [Abstract] [Full Text] [Related]

  • 6. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S, Boiroux D, Ranjan A, Jørgensen JB, Madsen H, Nørgaard K.
    Ther Deliv; 2015 Mar; 6(5):609-19. PubMed ID: 26001176
    [Abstract] [Full Text] [Related]

  • 7. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A, Legault L, Messier V, Mitre TM, Leroux C, Rabasa-Lhoret R.
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [Abstract] [Full Text] [Related]

  • 8. The Impact of Technology on Current Diabetes Management.
    Garvey K, Wolfsdorf JI.
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [Abstract] [Full Text] [Related]

  • 9. Closed loop insulin delivery in diabetes.
    Battelino T, Omladič JŠ, Phillip M.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [Abstract] [Full Text] [Related]

  • 10. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P, Soto N, Codner E.
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [Abstract] [Full Text] [Related]

  • 11. Who needs an artificial pancreas? (？).
    Winikoff J, Drexler A.
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [Abstract] [Full Text] [Related]

  • 12. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T, Nir J, Remus K, Farfel A, Muller I, Biester S, Atlas E, Dovc K, Bratina N, Kordonouri O, Battelino T, Philip M, Danne T, Nimri R.
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [Abstract] [Full Text] [Related]

  • 13. Emerging Technologies for the Management of Type 1 Diabetes in Pregnancy.
    Yamamoto JM, Murphy HR.
    Curr Diab Rep; 2018 Jan 30; 18(1):4. PubMed ID: 29383544
    [Abstract] [Full Text] [Related]

  • 14. Surgical options for glycaemic control in Type 1 diabetes.
    Yeung KTD, Reddy M, Purkayastha S.
    Diabet Med; 2019 Apr 30; 36(4):414-423. PubMed ID: 30575115
    [Abstract] [Full Text] [Related]

  • 15. What Matters Most. People weigh in on why they use their diabetes management products.
    Wahowiak L.
    Diabetes Forecast; 2016 Apr 30; 69(2):46-9. PubMed ID: 27048048
    [No Abstract] [Full Text] [Related]

  • 16. Emerging Technologies for Diabetes Care.
    Bailey TS, Walsh J, Stone JY.
    Diabetes Technol Ther; 2018 Jun 30; 20(S2):S278-S284. PubMed ID: 29916738
    [Abstract] [Full Text] [Related]

  • 17. Continuous glucose monitoring and pumps.
    Cohen N.
    Aust Fam Physician; 2015 May 30; 44(5):284-7. PubMed ID: 26042400
    [Abstract] [Full Text] [Related]

  • 18. [Brazilian Diabetes Society consensus statement--intensive insulin therapy and insulin pump therapy].
    Malerbi D, Damiani D, Rassi N, Chacra AR, Niclewicz ED, Silva Filho RL, Dib SA.
    Arq Bras Endocrinol Metabol; 2006 Feb 30; 50(1):125-35. PubMed ID: 16628285
    [Abstract] [Full Text] [Related]

  • 19. Automated blood glucose control in type 1 diabetes: A review of progress and challenges.
    Bertachi A, Ramkissoon CM, Bondia J, Vehí J.
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar 30; 65(3):172-181. PubMed ID: 29279252
    [Abstract] [Full Text] [Related]

  • 20. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.
    Ang KH, Tamborlane WV, Weinzimer SA.
    Expert Opin Drug Deliv; 2015 Mar 30; 12(10):1579-82. PubMed ID: 26389567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.